Overview

PrEP at a Syringe Services Program

Status:
Not yet recruiting

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.

Phase:

Phase 4

Details

Lead Sponsor:

University of Miami

Treatments:

Emtricitabine tenofovir alafenamide